The Effect of Polycystic Ovary Syndrome Phenotypes on Quality of Life and Sexual Function

CompletedOBSERVATIONAL
Enrollment

176

Participants

Timeline

Start Date

September 25, 2024

Primary Completion Date

October 7, 2024

Study Completion Date

February 25, 2025

Conditions
Polycystic OvaryDepressionSexual Dysfunction
Interventions
OTHER

Female Sexual Function Index

As part of the study, data on the socio-demographic characteristics of the individuals is collected by means of personal interviews using a questionnaire. The results of laboratory tests required for the diagnosis of PCOS will be taken from hospital records. The Female Sexual Function Index (FSFI), the Beck Depression Inventory and the KF-36 quality of life assessment form will be completed in person and the total scores will be analyzed taking into account four different PCOS phenotypes.

Trial Locations (1)

06000

Etlik Zübeyde Hanım, Ankara

All Listed Sponsors
lead

Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital

OTHER

NCT06428786 - The Effect of Polycystic Ovary Syndrome Phenotypes on Quality of Life and Sexual Function | Biotech Hunter | Biotech Hunter